Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organisms Patent now opens up ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...

One stock that's been on my watch list for a while is CRISPR Therapeutics (NASDAQ: CRSP). The company has an intriguing ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...

A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using gene-editing technology, but critics argue the animals are genetically modified gray ...

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.

Regulatory bodies have issued national guidelines to ensure safe, ethical deployment of CRISPR-based therapies in India, while the BioE3 is accelerating indigenous capacity for cell and gene ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Caribou Biosciences offers the strongest allogeneic CAR-T data to date, with efficacy and safety. Read why I am bullish about ...